In vivo distribution of 125I-radiolabelled solid lipid nanoparticles

Pharmazeutische Industrie

Volumn 68, Issue 7, 2006, Pages 889-894

  Weyhers, Holger ^a   Löbenberg, Raimar ^b   Mehnert, Wolfgang ^a   Souto, Eliana B ^a   Kreuter, Jörg ^b   Müller, Rainer H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Poloxamer 407; Poloxamine 908; SLN; Solid lipid nanoparticles, in vivo distribution; Tween 80

Indexed keywords

DRUG CARRIER; IODINE 125; RADIOISOTOPE; SOLID LIPID NANOPARTICLE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; ISOTOPE LABELING; LIVER; MONONUCLEAR PHAGOCYTE; NONHUMAN; ORGAN DISTRIBUTION; RADIOACTIVITY; RAT; SPLEEN;

EID: 33749488961     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kreuter, J., Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 47, 65 (2001)
2. Davis, S. S., Coming of age of lipid-based drug delivery systems. Adv. Drug Deliv. Rev. 56, 1241 (2004)
3. Müller, R. H., Colloidal carriers for controlled drug delivery and targeting. Modification, characterisation and in vivo distribution, CRC Press, Boca Raton (1991)
4. Van Oss, C. J., Absolom, D. R., Neumann, A. W., Interaction of phagocytes with other blood cells and with pathogenic and nonpathogenic microbes. Ann. N. Y. Acad. Sci. 416, 332 (1983)
5. Kreuter, J., Evaluation of nanoparticles as drug-delivery systems. III: materials, stability, toxicity, possibilities of targeting, and use. Pharm. Acta Helv. 58, 242 (1983)
6. Kreuter, J., Evaluation of nanoparticles as drug-delivery systems. II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 micron), liposomes, and emulsions. Pharm. Acta Helv. 58, 217 (1983)
7. Couvreur, P., Fattal, E., Andremont, A., Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm. Res. 8, 1079 (1991)
8. Douglas, S. J., Davis, S. S., Ilium, L., Nanoparticles in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 3, 233 (1987)
9. Redhead, H. M., Davis, S. S., Ilium, L., Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release 70, 353 (2001)
10. Moghimi, S. M., Illum, L., Davis, S. S., Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow. Crit. Rev. Ther. Drug Carrier Syst. 7, 187 (1990)
11. Blunk, T., Hochstrasser, D. F., Sanchez, J.-C. et al., Colloidal carriers for intravenous drug targeting: plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 14, 1382 (1993)
12. Ilium, L., Davis, S. S., Müller, R. H. et al., The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer - poloxamine 908. Life Sci. 40, 367 (1987)
13. Illum, L., Davis, S. S., Targeting of colloidal particles to the bone marrow. Life Sci. 40, 1553 (1987)
14. Porter, C. J., Moghimi, S. M, Illum, L. et al., The polyoxyethylene/ polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEES Lett. 305, 62 (1992)
15. Rawlins, D. A. Kayes, J. B., Steric stabilization: the effect of adsorbed polymers on suspension redispersibility [proceedings]. J. Pharm. Pharmacol. 31 (Suppl.), 50P (1979)
16. Kayes, J. B., Rawlins, D. A., Steric stabilization of suspensions, the adsorbed polymer layer thickness. J. Pharm. Pharmacol. 30 (Suppl.), 75P (1978)
17. Blunk, T., Plasmaproteinadsorption auf kolloidalen Arzneistoffträ gern - Analytik, Korrelation mit Oberflächeneigenschaften, Implikationen für das Drug Targeting. Ph.D. Thesis, University of Kiel, Kiel (1994)
18. Illum, L., West, P., Washington, P. et al., The effect of stabilising agents on the organs distribution of lipid emulsions. Int. J. Pharm. 54, 41 (1989)
19. Müller, R. H., Lucks, J. S., Arzneistoffträger aus festen Lipidteilchen, Feste Lipidnanosphären (SLN). European Patent 0605497, Germany (1991)
20. Müller, R. H., Mäder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of art. Eur. J. Pharm. Biopharm. 50, 161 (2000)
21. Müller, R. H., Keck, C. M., Challenges and solutions for the delivery of biotech drugs - A review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. 113, 151 (2004)
22. Müller, R. H., Mehnert, W., Souto, E. B., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery, in: Percutaneous Absorption, L. Bronaugh (ed.), pp. 719-738. Marcel Dekker, New York-Basel etc. (2005)
23. Wissing, S. A., Kayser, O., Müller, R. H., Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56, 1257 (2004)
24. Weyhers, H., Mehnert, W., Müller, R. H., Production and characterization of surface-modified solid lipid nanoparticles (SLN). Eur. J. Pharm. Biopharm. 40 (Suppl.), 41S (1994)
25. Müller, R. H., Maaßen, S., Weyhers, H. et al., Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J. Drug Target. 4, 161 (1996)
26. Weyhers, H., Feste Lipid-Nanopartikel (SLN) für die gewebsspezifische Arzneistoffapplikation - Herstellung, Charakterisierung oberflächenmodifizierter Formulierungen. Ph.D. Thesis, Freie Universität Berlin, Berlin (1995)
27. Tröster, S., Veränderung der Körperverteilung kolloidaler Arzneistoffträger, speziell von Nanopartikeln nach intravenöser Applikation. Ph.D. Thesis, University of Frankfurt/Main, Frankfurt/Main (1990)
28. Borchard, G., Untersuchungen von Interaktionen kolloidaler Arzneistoffträger (Nanopartikel) mit Bestandteilen des retikuloendothelialen Systems bei Ratten: Charakterisierung der die Körperverteilung beeinflussenden Faktoren. Ph.D. Thesis, University of Frankfurt/Main, Frankfurt/Main (1993)
29. Weyhers, H., Ehlers, S., Mehnert, W. et al., Solid lipid nanoparticles - Determination of in vivo toxicity. Proceedings of the First World Meeting APGI/APV Budapest, 1995, pp. 489-490
30. Gudewicz, P. W., Molnar, J., Lai, M. Z. et al., Fibronectin-mediated uptake of gelatin-coated latex particles by peritoneal macrophages. J. Cell Biol. 87, 427 (1980)
31. Tröster, S., Müllerm U., Kreuter, J., Modification of the body distribution of poly(methylmethacrylate) nanoparticles in rats by coating with surfactants. Int. J. Pharm. 61, 85 (1990)